The U.S. Meals and Drug Administration stated on Friday it will take motion towards telehealth supplier Hims & Hers for its $49 weight-loss capsule, together with limiting entry to the drug’s elements and referring the corporate to the Division of Justice for potential violations of federal regulation.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
